GWS
NVCR icon

Glassman Wealth Services’s NovoCure NVCR Stock Holding History

Glassman Wealth Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24
Closed -$996 – 2039
2023
Q2 		$996 Sell
24
-8
-25% -$497 ﹤0.01% 1446
2023
Q1 		$1.92K Buy
32
+5
+19% +$400 ﹤0.01% 1259
2022
Q4 		$1.98K Hold
27
– – ﹤0.01% 1258
2022
Q3 		$2K Sell
27
-2
-7% -$156 ﹤0.01% 1241
2022
Q2 		$2K Buy
+29
New +$2.19K ﹤0.01% 1263
2020
Q2 		– Sell
-8
Closed -$1K – 1438
2020
Q1 		$1K Buy
8
+4
+100% +$316 ﹤0.01% 942
2019
Q4 		$0 Hold
4
– – ﹤0.01% 1385
2019
Q3 		$0 Hold
4
– – ﹤0.01% 1275
2019
Q2 		$0 Buy
+4
New +$203 ﹤0.01% 1275

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Glassman Wealth Services's NVCR Position: Q3 2023 in Review

Glassman Wealth Services sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 24 shares — an estimated $996 sold.

Glassman Wealth Services first reported a position in NVCR in Q2 2019 and held it in 9 quarters. The position peaked at $2K in Q3 2022. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Glassman Wealth Services reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 24 NovoCure shares in Q3 2023, an estimated $996.
  • Glassman Wealth Services first reported a position in NovoCure in Q2 2019 and held it in 9 quarters.
  • Glassman Wealth Services's NovoCure position peaked at $2K in Q3 2022.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Glassman Wealth Services's 13F filing for Q3 2023, filed 14 Nov 2023.